Clinical trials
Phase 1 Breast Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
1,412 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 11 |
| 2001 | 21 |
| 2002 | 17 |
| 2003 | 20 |
| 2004 | 24 |
| 2005 | 36 |
| 2006 | 42 |
| 2007 | 49 |
| 2008 | 54 |
| 2009 | 57 |
| 2010 | 54 |
| 2011 | 50 |
| 2012 | 49 |
| 2013 | 55 |
| 2014 | 59 |
| 2015 | 50 |
| 2016 | 69 |
| 2017 | 66 |
| 2018 | 69 |
| 2019 | 63 |
| 2020 | 79 |
| 2021 | 59 |
| 2022 | 68 |
| 2023 | 66 |
| 2024 | 65 |
| 2025 | 54 |
| 2026 | 47 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 796 |
| Terminated | 175 |
| Recruiting | 152 |
| Unknown status | 95 |
| Active, not recruiting | 92 |
| Withdrawn | 69 |
| Not yet recruiting | 20 |
| Suspended | 8 |
| Enrolling by invitation | 5 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 86 |
| M.D. Anderson Cancer Center | 32 |
| Novartis Pharmaceuticals | 32 |
| Memorial Sloan Kettering Cancer Center | 29 |
| Pfizer | 26 |
| AstraZeneca | 23 |
| Mayo Clinic | 19 |
| Dana-Farber Cancer Institute | 18 |
| Eli Lilly and Company | 17 |
| GlaxoSmithKline | 17 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Neoplasms | 1,412 |
| Ovarian Neoplasms | 220 |
| Carcinoma, Non-Small-Cell Lung | 165 |
| Colorectal Neoplasms | 162 |
| Pancreatic Neoplasms | 158 |
| Lung Neoplasms | 152 |
| Prostatic Neoplasms | 140 |
| Stomach Neoplasms | 140 |
| Neoplasms | 139 |
| Neoplasm Metastasis | 130 |
Trials
Showing 26 to 50 of 1,412. Each trial links to its page on Pharma Observatory.
1,312 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.